Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Roger's Company
View:
Post by bartlman on Sep 14, 2021 12:42pm

Roger's Company

"I sometimes get the feeling that our old CEO will be our next CEO, back in the saddle again once the OSC wrist slap is over and that mighy not be a bad thing, the company was more exciting then." 

An interesting thought and I couldn't agree more. How long is Roger's progbation or ex-communication however you wish to phrase it? No doubt though that this is Roger's company....
Comment by Kingpin68 on Sep 14, 2021 2:49pm
The OSC agreement seems to indicate 5 years, from Feb 2018, before Roger could take on a position as a Director again. That puts it at Feb 2023. Not too far off.
Comment by bartlman on Sep 14, 2021 3:19pm
Indeed. About 1 year and 4 months. Thanks Kingpin.
Comment by DJDawg on Sep 14, 2021 3:22pm
can someone teach us newer investors...what did he do to get this prohibition?
Comment by Eoganacht on Sep 14, 2021 3:49pm
He was overly optimistic about the release date of the TLC-2000 laser. https://www.osc.ca/en/tribunal/tribunal-proceedings/theralase-technologies-inc-re/settlement-agreement-matter-theralase-technologies-inc-and-roger-dumoulin-white
Comment by tamarindo1 on Sep 14, 2021 4:07pm
There are mixed feelings about Roger's punishment. Some thought it was fully deserved, others thought that the OSC was just a bit too brutal. Considering some of the shenanigans that occurs on the TSXV, which I feel has been created by OSC.s removal of the uptick rule.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250